M. Korppi (Kuopio, Finland), M. Canciani (Udine, Italy)
Montelukast is not preventing reactive airway disease in post respiratory syncytial virus bronchiolitis
K. Sauer, E. Govaere, M. Raes, G. Debildering, K. De Boeck (Leuven, Hasselt, Mont-goddine, Belgium)
|  |
Viral lower respiratory tract infections and respiratory morbidity in prematurely born infants at follow up
S. Broughton, A. Helen, A. Roberts, G. Fox, M. Zuckerman, A. Greenough (London, United Kingdom)
|  |
Efficacy of recombinant human deoxyribonuclease (Rh-DNase) in infants hospitalised with respiratory syncytial virus bronchiolitis: a multicentre randomised double-blind clinical trial
R. Boogaard, A. R. Hulsmann, W. C. J. Hop, P. J. F. M. Merkus, the Dnase-RSV Study Group (Rotterdam, Breda, Netherlands)
| |
RSV lower respiratory tract infection and cytokine profile in prematurely born infants
S. Broughton, G. Lombardi, G. Fox, M. Zuckerman, A. Greenough (London, United Kingdom)
| |
Recombinant human deoxyribonuclease treatment in hospital management of infants with moderate-severe bronchiolitis
E. Corazzesi, R. Nenna, V. Tromba, R. Tuccinardi, S. Piacenti, F. Scalercio, E. Trapasso, S. Brenna, C. Moretti, F. Midulla (Rome, Italy)
| |
Palivizumab prophylaxis, respiratory syncytial virus and subsequent recurrent wheezing: a 2-year follow-up study
E. A. F. Simoes, J. R. Groothuis, X. Carbonell-Estrany, I. Mitchell, L. M. Fredrick, J. L. Kimpen (Denver, San Diego, Abbott Park, United States Of America; Barcelona, Spain; Bochum, Germany; Utrecht, Netherlands)
| |
Human neutrophil elastase (HNE) in acute bronchiolitis
C. Magnisali, M. Eboriadou, M. Hatzistylianou, A. Sakellaropoulou, G. Skouli, V. Aivazis (Thessaloniki, Greece)
| |
Early exposure or sensitization to pets and subsequent asthma: a 20-year prospective post-bronchiolitis follow-up
E. Piippo-Savolainen, S. Remes, M. Korppi (Kuopio, Finland)
| |